<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02429557</url>
  </required_header>
  <id_info>
    <org_study_id>140634</org_study_id>
    <secondary_id>1R01HL144568-01A1</secondary_id>
    <nct_id>NCT02429557</nct_id>
  </id_info>
  <brief_title>Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure</brief_title>
  <official_title>Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Vanderbilt University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Compression garments have been shown to be effective in the treatment of orthostatic&#xD;
      hypotension in autonomic failure patients. The purpose of this study is to determine the&#xD;
      hemodynamic mechanisms by which abdominal compression (up to 40 mm Hg) improve the standing&#xD;
      blood pressure and orthostatic tolerance in these patients, and to compare them with those of&#xD;
      the standard of care midodrine. The investigators will test the hypothesis that abdominal&#xD;
      compression will blunt the exaggerated fall in stroke volume and the increase in abdominal&#xD;
      vascular volume during head up tilt.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with autonomic failure are characterized by disabling orthostatic hypotension (low&#xD;
      blood pressure on standing) due to severe impairment of the autonomic nervous system.&#xD;
      Compression garments such as waist-high stockings and abdominal binders have been shown to&#xD;
      improve orthostatic hypotension in these patients. The purpose of this study is to determine&#xD;
      the hemodynamic mechanisms by which abdominal compression (up to 40 mm Hg) improve the&#xD;
      standing blood pressure and orthostatic tolerance in these patients, and to compare them with&#xD;
      those of the standard of care midodrine. The investigators will test the hypothesis that&#xD;
      abdominal compression will blunt the exaggerated fall in stroke volume and the increase in&#xD;
      abdominal vascular volume during head up tilt. This study will help us better understand the&#xD;
      contribution of the abdominal veins to orthostatic hypotension and the mechanisms underlying&#xD;
      this non-pharmacological therapeutic approach.&#xD;
&#xD;
      Participants will be studied in a tilt table in two separate days in a randomized, crossover&#xD;
      fashion with sham abdominal compression (~5 mmHg) and active compression (~40 mmHg).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 2015</start_date>
  <completion_date type="Anticipated">December 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2024</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Stroke volume</measure>
    <time_frame>an average of 15 minutes of head up tilt</time_frame>
    <description>Percent change from supine in stroke volume during head up tilt</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Systolic blood pressure</measure>
    <time_frame>an average of 15 minutes of head up tilt</time_frame>
    <description>Change from baseline in systolic blood pressure during head up tilt</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Splanchnic vascular volume</measure>
    <time_frame>an average of 15 minutes of head up tilt</time_frame>
    <description>Percent change from supine in splanchnic vascular volume during head up tilt.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">29</enrollment>
  <condition>Orthostatic Hypotension</condition>
  <condition>Pure Autonomic Failure</condition>
  <condition>Multiple System Atrophy</condition>
  <condition>Autonomic Failure</condition>
  <arm_group>
    <arm_group_label>Abdominal compression and placebo pill</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Abdominal compression with an inflatable abdominal binder (up to 40 mmHg) during head up tilt, and placebo pill given 1 hour before the second head up tilt</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham abdominal compression and placebo</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham abdominal compression with an inflatable abdominal binder (~5 mmHg) during head up tilt, and placebo pill given 1 hour before the second head up tilt</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Abdominal compression and midodrine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Abdominal compression with an inflatable abdominal binder (up to 40 mmHg) during head up tilt, and midodrine 2.5-10 mg PO given 1 hour before the second head up tilt</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham abdominal compression and midodrine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Sham abdominal compression with an inflatable abdominal binder (~5 mmHg) during head up tilt, and midodrine 2.5-10mg PO given 1 hour before the second head up tilt</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Abdominal compression</intervention_name>
    <description>Abdominal compression of 40 mmHg with a commercial inflatable cuff applied during head up tilt</description>
    <arm_group_label>Abdominal compression and midodrine</arm_group_label>
    <arm_group_label>Abdominal compression and placebo pill</arm_group_label>
    <other_name>abdominal binder</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sham abdominal compression</intervention_name>
    <description>Sham abdominal compression of 5 mmHg with a commercial inflatable cuff applied during head up tilt</description>
    <arm_group_label>Sham abdominal compression and midodrine</arm_group_label>
    <arm_group_label>Sham abdominal compression and placebo</arm_group_label>
    <other_name>abdominal binder</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo pill</intervention_name>
    <description>Placebo pill given 1 hour before the second heat up tilt</description>
    <arm_group_label>Abdominal compression and placebo pill</arm_group_label>
    <arm_group_label>Sham abdominal compression and placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>midodrine</intervention_name>
    <description>Midodrine single dose 2.5-10mg PO given 1 hour before the second head up tilt</description>
    <arm_group_label>Abdominal compression and midodrine</arm_group_label>
    <arm_group_label>Sham abdominal compression and midodrine</arm_group_label>
    <other_name>ProAmatine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male and female patients,&#xD;
&#xD;
          -  between 18-80 yrs.,&#xD;
&#xD;
          -  with neurogenic orthostatic hypotension associated with primary autonomic failure&#xD;
             (Parkinson Disease, Multiple System Atrophy and Pure Autonomic Failure). Orthostatic&#xD;
             hypotension will be defined as ≥20 mmHg decrease in systolic BP or ≥10 mmHg of&#xD;
             diastolic BP within 3 minutes on standing associated with impaired autonomic reflexes&#xD;
             determined by autonomic testing in the absence of other identifiable causes (Freeman&#xD;
             et al., 2011).&#xD;
&#xD;
          -  Patients able and willing to provide informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy.&#xD;
&#xD;
          -  Significant cardiac, renal or hepatic illness, or with contraindications to&#xD;
             administration of pressor agents or external abdominal compression will be excluded.&#xD;
&#xD;
          -  Clinically unstable coronary artery disease, or major cardiovascular or neurological&#xD;
             event in the past 6 months, and; other factors which in the investigator's opinion&#xD;
             would prevent the subject from completing the protocol including clinically&#xD;
             significant abnormalities in clinical, mental or laboratory testing&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Italo Biaggioni, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Luis E Okamoto, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt University Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Emily C Smith, RN</last_name>
    <phone>615.875.1516</phone>
    <email>autonomics@vumc.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bonnie K Black, RN</last_name>
    <phone>615-322-3304</phone>
    <email>autonomics@vumc.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Vanderbilt University</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emily C Smith, RN</last_name>
      <phone>615-875-1516</phone>
      <email>autonomics@vumc.org</email>
    </contact>
    <contact_backup>
      <last_name>Bonnie K Black, RN</last_name>
      <phone>615-322-3304</phone>
      <email>autonomics@vumc.org</email>
    </contact_backup>
    <investigator>
      <last_name>Italo Biaggioni, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alfredo Gamboa, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Luis E Okamoto, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cyndya A Shibao, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andre Diedrich, MD/PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Emily C Smith, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>April 21, 2015</study_first_submitted>
  <study_first_submitted_qc>April 23, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 29, 2015</study_first_posted>
  <last_update_submitted>November 11, 2021</last_update_submitted>
  <last_update_submitted_qc>November 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University Medical Center</investigator_affiliation>
    <investigator_full_name>Luis E Okamoto</investigator_full_name>
    <investigator_title>Research Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>autonomic failure</keyword>
  <keyword>orthostatic hypotension</keyword>
  <keyword>compression garments</keyword>
  <keyword>treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypotension, Orthostatic</mesh_term>
    <mesh_term>Multiple System Atrophy</mesh_term>
    <mesh_term>Shy-Drager Syndrome</mesh_term>
    <mesh_term>Pure Autonomic Failure</mesh_term>
    <mesh_term>Hypotension</mesh_term>
    <mesh_term>Atrophy</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Midodrine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

